novo glp 1 drugs Details of failed studies cast pall on Nordisk's GLP-1 as Alzheimer's treatment GLP-1s for Alzheimer's: Novo Nordisk
Description
Ann Intern Med 176(3):427429
GLP-1 medications address multiple parts of this equation simultaneously
Activation of this receptor also slows gastric emptying, promotes satiety, and reduces food intake, contributing to weight management and appetite control
At Rs 1,0002,500 a month, it's cheaper than a gym membership
N Engl J Med 2021;384:1719-30.ArticlePubMed 31
GLP-1 receptor agonist NLY01 reduces retinal inflammation and neuron death secondary to ocular hypertension
